KEAP1 and depressive disorder: Another study suggests that major depressive disorder (MDD) patients’ parietal cortex showed lower levels of Nrf2 and Keap1 expression than the control group, suggesting that decreased Keap1–Nrf2 signaling could be a major factor in the onset of depression [108].